Ali Asghar Okhovat
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ali Asghar Okhovat has a total of 128 co-authors. Here are the top co-authors by number of shared publications:
- Farzad Fatehi
Neuromuscular Research Center, Department of Neurology, Shariati Hospital Tehran University of Medical Sciences Tehran Iran
10 shared publications - Shahriar Nafissi
Neuromuscular Research Center, Tehran University of Medical Sciences, Tehran, Iran
10 shared publications - Behnaz Ansari
Isfahan University of Medical Sciences
6 shared publications Bahram Haghi Ashtiani
Neurology Department Firouzgar Hospital, Iran University of Medical Sciences Tehran Iran
5 shared publicationsAkram Panahi
Neurology Department Iranian Neuromuscular Research Center, Shariati Hospital, Tehran University of Medical Sciences Tehran Iran
4 shared publications- Keivan Basiri
Department of Neurology, School of Medicine, Al-Zahra Hospital, Isfahan University of Medical Sciences, Isfahan, Iran
4 shared publications
Latest Publications
- 6 November 2026
- Published by Springer Nature in Molecular Biology Reports
- Vol. 53 (1) , 1910
Identification of AKAP6 as a candidate gene for charcot–marie–tooth disease: expanding the clinical and molecular spectrum
- 6 November 2026
- Published by Springer Nature in Molecular Biology Reports
- Vol. 53 (1) , 1910
Identification of AKAP6 as a candidate gene for charcot–marie–tooth disease: expanding the clinical and molecular spectrum
- Open Access
- 22 October 2026
- Published by Wiley in Molecular Genetics & Genomic Medicine
- Vol. 14 (10) , e70312
Variable Phenotypic Manifestations of Novel Compound Heterozygous CRPPA Variants in Two Iranian Siblings With Limb‐Girdle Muscular Dystrophy
Background: Dystroglycanopathies are a clinically and genetically heterogeneous group of muscular dystrophies caused by impaired glycosylation of α ‐dystroglycan, with variants in multiple genes, including CRPPA , which is associated with a broad spectrum ranging from congenital muscular dystrophy to limb‐girdle muscular dystrophy. Method: The proband underwent whole exome sequencing, while Sanger sequencing was used for segregation analysis and oligonucleotide array‐CGH was performed to confirm the copy number variant. Results: We report two siblings harboring an identical novel compound heterozygous CRPPA genotype, comprising a novel c.267G>C missense variant and a deletion encompassing exons 9–10. Despite sharing the same genotype, the siblings showed marked phenotypic variability. The female sibling developed childhood‐onset disease with proximal weakness involving both the upper and lower limbs, whereas the male sibling presented with late‐onset disease and weakness confined to the proximal lower limbs, accompanied by markedly discordant serum creatine kinase levels (1193 vs. 460 U/L). Conclusion: These findings expand the mutational and clinical spectrum of CRPPA‐related dystroglycanopathy, highlight marked intrafamilial phenotypic variability, and emphasize the importance of integrated single‐nucleotide and copy number variant analysis in the genetic diagnosis of neuromuscular disorders.
- 22 October 2026
- Published by Wiley in Molecular Genetics & Genomic Medicine
- Vol. 14 (10) , e70312
Open AccessVariable Phenotypic Manifestations of Novel Compound Heterozygous CRPPA Variants in Two Iranian Siblings With Limb‐Girdle Muscular Dystrophy
Background: Dystroglycanopathies are a clinically and genetically heterogeneous group of muscular dystrophies caused by impaired glycosylation of α ‐dystroglycan, with variants in multiple genes, including CRPPA , which is associated with a broad spectrum ranging from congenital muscular dystrophy to limb‐girdle muscular dystrophy. Method: The proband underwent whole exome sequencing, while Sanger sequencing was used for segregation analysis and oligonucleotide array‐CGH was performed to confirm the copy number variant. Results: We report two siblings harboring an identical novel compound heterozygous CRPPA genotype, comprising a novel c.267G>C missense variant and a deletion encompassing exons 9–10. Despite sharing the same genotype, the siblings showed marked phenotypic variability. The female sibling developed childhood‐onset disease with proximal weakness involving both the upper and lower limbs, whereas the male sibling presented with late‐onset disease and weakness confined to the proximal lower limbs, accompanied by markedly discordant serum creatine kinase levels (1193 vs. 460 U/L). Conclusion: These findings expand the mutational and clinical spectrum of CRPPA‐related dystroglycanopathy, highlight marked intrafamilial phenotypic variability, and emphasize the importance of integrated single‐nucleotide and copy number variant analysis in the genetic diagnosis of neuromuscular disorders.
- 2 October 2026
- Published by Springer Nature in Current Genetic Medicine Reports
- Vol. 14 (1) , 38
Focal Demyelinating Electrophysiological Features in MTRFR-Related Spastic Paraplegia Type 55 (SPG55): A Case Report
- 2 October 2026
- Published by Springer Nature in Current Genetic Medicine Reports
- Vol. 14 (1) , 38
Focal Demyelinating Electrophysiological Features in MTRFR-Related Spastic Paraplegia Type 55 (SPG55): A Case Report
Comparison of median nerve conduction parameters from the index and middle fingers in carpal tunnel syndrome: Toward a standardized electrophysiological evaluation protocol
Background: Variability exists regarding which is the best digit for diagnosing and classifying the severity of carpal tunnel syndrome (CTS) with electrodiagnostic studies. Objective: To compare nerve conduction parameters—peak sensory latency, amplitude, and conduction velocity—of the median nerve between the index and middle fingers in patients with mild to moderate CTS and to assess the diagnostic value of interdigit latency differences. Design: Diagnostic study with the gold standard of electrodiagnosis. Setting: Department of physical medicine and rehabilitation at a tertiary hospital affiliated with a university of medical sciences. Participants: Participants were adult patients with a clinical diagnosis of primary idiopathic mild ( n = 53) or moderate ( n = 53) CTS, along with a control group ( n = 53) with no electrodiagnostic evidence of CTS. Interventions: Not applicable. Main Outcome Measure: Antidromic sensory nerve conduction studies were performed on the index and middle fingers, and the parameters were compared among the study groups. Linear regression and supervised machine learning models, adjusted for age and body mass index, were used to evaluate diagnostic performance. Results: Peak sensory latencies increased with the severity of CTS for both the index and middle fingers (both p <.001). The difference in interdigit latency also increased significantly with syndrome severity ( p < .001). Post hoc tests revealed significant differences in interdigit latencies for all pairwise comparisons among the study groups (all p < .001). Multivariable models adjusted for age and body mass index achieved the highest diagnostic accuracy for middle finger latency (area under the receiver operating characteristic curve = 0.973, p < .001). The interdigit latency difference model demonstrated the highest sensitivity (90%) for moderate CTS. Conclusions: Middle finger peak latency outperformed index finger recordings and interdigit latency comparisons in diagnosing CTS. Adding middle finger peak latency and interdigit latency difference to standard electrodiagnostic protocols improves early detection and classification of the syndrome.
Comparison of median nerve conduction parameters from the index and middle fingers in carpal tunnel syndrome: Toward a standardized electrophysiological evaluation protocol
Background: Variability exists regarding which is the best digit for diagnosing and classifying the severity of carpal tunnel syndrome (CTS) with electrodiagnostic studies. Objective: To compare nerve conduction parameters—peak sensory latency, amplitude, and conduction velocity—of the median nerve between the index and middle fingers in patients with mild to moderate CTS and to assess the diagnostic value of interdigit latency differences. Design: Diagnostic study with the gold standard of electrodiagnosis. Setting: Department of physical medicine and rehabilitation at a tertiary hospital affiliated with a university of medical sciences. Participants: Participants were adult patients with a clinical diagnosis of primary idiopathic mild ( n = 53) or moderate ( n = 53) CTS, along with a control group ( n = 53) with no electrodiagnostic evidence of CTS. Interventions: Not applicable. Main Outcome Measure: Antidromic sensory nerve conduction studies were performed on the index and middle fingers, and the parameters were compared among the study groups. Linear regression and supervised machine learning models, adjusted for age and body mass index, were used to evaluate diagnostic performance. Results: Peak sensory latencies increased with the severity of CTS for both the index and middle fingers (both p <.001). The difference in interdigit latency also increased significantly with syndrome severity ( p < .001). Post hoc tests revealed significant differences in interdigit latencies for all pairwise comparisons among the study groups (all p < .001). Multivariable models adjusted for age and body mass index achieved the highest diagnostic accuracy for middle finger latency (area under the receiver operating characteristic curve = 0.973, p < .001). The interdigit latency difference model demonstrated the highest sensitivity (90%) for moderate CTS. Conclusions: Middle finger peak latency outperformed index finger recordings and interdigit latency comparisons in diagnosing CTS. Adding middle finger peak latency and interdigit latency difference to standard electrodiagnostic protocols improves early detection and classification of the syndrome.
- 2 March 2026
- Published by Springer Nature in Journal of Human Genetics
- Vol. 71 (7) , 453-459
Expanding the phenotypic spectrum of LAMA2-related disorders: Axonal neuropathy in the absence of muscular dystrophy
The LAMA2 gene encodes the alpha-2 chain of laminin-2, a key component of the basement membrane that maintains muscle fiber stability and integrity. Mutations in this gene are linked with LAMA2-related muscular dystrophies, which includes congenital muscular dystrophy type 1 A (MDC1A) and limb-girdle muscular dystrophy autosomal recessive 23 (LGMDR23). Here, we present two siblings from one of 200 unrelated Iranian Charcot-Marie-Tooth (CMT) families, exhibiting axonal sensorimotor polyneuropathy, without any clinical signs of muscular dystrophy, carrying a homozygous variant in the LAMA2 gene. Following clinical and paraclinical assessments of the patients, genomic DNA was extracted from peripheral blood samples. Whole-exome sequencing (WES) was employed to identify potential genetic variants, and Sanger sequencing was subsequently used to confirm the detected variant. In silico prediction tools were further applied to evaluate the potential pathogenicity and functional impact of the identified variant. A homozygous missense variant in the LAMA2 gene, c.2916 T > G; p.Phe972Leu, was identified and co-segregated with the disease status within the family, whose neurological assessments confirmed axonal sensorimotor polyneuropathy. So far, only two studies have reported LAMA2 variants in patients only manifesting a neuropathy phenotype. None of these studies reported the detailed clinical data of their cases. However, our study provides further evidence of the association between LAMA2 mutations and neuropathy, and includes comprehensive clinical and paraclinical characterization of the affected individuals. Our findings underscore the importance of comprehensive genomic testing in diagnosing neuromuscular disorders and expand the phenotypic spectrum associated with LAMA2 mutations.
- 2 March 2026
- Published by Springer Nature in Journal of Human Genetics
- Vol. 71 (7) , 453-459
Expanding the phenotypic spectrum of LAMA2-related disorders: Axonal neuropathy in the absence of muscular dystrophy
The LAMA2 gene encodes the alpha-2 chain of laminin-2, a key component of the basement membrane that maintains muscle fiber stability and integrity. Mutations in this gene are linked with LAMA2-related muscular dystrophies, which includes congenital muscular dystrophy type 1 A (MDC1A) and limb-girdle muscular dystrophy autosomal recessive 23 (LGMDR23). Here, we present two siblings from one of 200 unrelated Iranian Charcot-Marie-Tooth (CMT) families, exhibiting axonal sensorimotor polyneuropathy, without any clinical signs of muscular dystrophy, carrying a homozygous variant in the LAMA2 gene. Following clinical and paraclinical assessments of the patients, genomic DNA was extracted from peripheral blood samples. Whole-exome sequencing (WES) was employed to identify potential genetic variants, and Sanger sequencing was subsequently used to confirm the detected variant. In silico prediction tools were further applied to evaluate the potential pathogenicity and functional impact of the identified variant. A homozygous missense variant in the LAMA2 gene, c.2916 T > G; p.Phe972Leu, was identified and co-segregated with the disease status within the family, whose neurological assessments confirmed axonal sensorimotor polyneuropathy. So far, only two studies have reported LAMA2 variants in patients only manifesting a neuropathy phenotype. None of these studies reported the detailed clinical data of their cases. However, our study provides further evidence of the association between LAMA2 mutations and neuropathy, and includes comprehensive clinical and paraclinical characterization of the affected individuals. Our findings underscore the importance of comprehensive genomic testing in diagnosing neuromuscular disorders and expand the phenotypic spectrum associated with LAMA2 mutations.
- 28 November 2025
- Published by Wiley in Muscle & Nerve
- Vol. 73 (2) , 240-249
A Cohort of Iranian Patients With Congenital Myasthenic Syndrome due to Glycosylation Defects
Introduction/Aims: Glycosylation defects are a recognized cause of congenital myasthenic syndrome (CMS), affecting the stability and functions of the neuromuscular junction proteins. Mutations in five genes ( GFPT1 , DPAGT1 , GMPPB , ALG2 , and ALG14 ) are currently associated with glycosylation‐related CMS. This cohort describes Iranian patients with CMS and variants in these genes. Methods: A retrospective study was conducted to examine demographic, clinical, genetic, and histological data from Iranian patients with confirmed CMS‐glycosylation defects. Patients were identified and recruited through the Neuromuscular Clinics of Tehran University of Medical Sciences. Only patients with complete clinical and genetic data available were included. Results: Twenty‐three genetically confirmed patients with glycosylation‐related CMS were enrolled. Genetic analysis revealed the mutations in the GFPT1 , GMPPB , and ALG2 genes, with those in GFPT1 and GMPPB being the most common. The median age of onset and diagnosis was 6 and 16 years, respectively. Common clinical features were limb‐girdle muscle weakness with minimal ocular involvement. Consanguinity and a positive family history were common, identified in 21 and 14 patients, respectively. Muscle biopsies revealed tubular aggregates in patients with GFPT1 and GMPPB variants. In addition, novel genetic variants were identified, and phenotypic variability was observed even within families sharing identical mutations. Discussion: This study identifies novel variants and phenotypic variability in glycosylation‐related CMS, with GFPT1 and GMPPB as the predominant subtypes in Iran. These findings expand the genotypic and phenotypic spectrum and underscore the importance of early genetic testing in high‐consanguinity populations to improve diagnosis and management.
- 28 November 2025
- Published by Wiley in Muscle & Nerve
- Vol. 73 (2) , 240-249
A Cohort of Iranian Patients With Congenital Myasthenic Syndrome due to Glycosylation Defects
Introduction/Aims: Glycosylation defects are a recognized cause of congenital myasthenic syndrome (CMS), affecting the stability and functions of the neuromuscular junction proteins. Mutations in five genes ( GFPT1 , DPAGT1 , GMPPB , ALG2 , and ALG14 ) are currently associated with glycosylation‐related CMS. This cohort describes Iranian patients with CMS and variants in these genes. Methods: A retrospective study was conducted to examine demographic, clinical, genetic, and histological data from Iranian patients with confirmed CMS‐glycosylation defects. Patients were identified and recruited through the Neuromuscular Clinics of Tehran University of Medical Sciences. Only patients with complete clinical and genetic data available were included. Results: Twenty‐three genetically confirmed patients with glycosylation‐related CMS were enrolled. Genetic analysis revealed the mutations in the GFPT1 , GMPPB , and ALG2 genes, with those in GFPT1 and GMPPB being the most common. The median age of onset and diagnosis was 6 and 16 years, respectively. Common clinical features were limb‐girdle muscle weakness with minimal ocular involvement. Consanguinity and a positive family history were common, identified in 21 and 14 patients, respectively. Muscle biopsies revealed tubular aggregates in patients with GFPT1 and GMPPB variants. In addition, novel genetic variants were identified, and phenotypic variability was observed even within families sharing identical mutations. Discussion: This study identifies novel variants and phenotypic variability in glycosylation‐related CMS, with GFPT1 and GMPPB as the predominant subtypes in Iran. These findings expand the genotypic and phenotypic spectrum and underscore the importance of early genetic testing in high‐consanguinity populations to improve diagnosis and management.
- 8 October 2025
- Published by Springer Nature in Current Genetic Medicine Reports
- Vol. 13 (1) , 1-9
Myo-Neuropathy and Congenital Bilateral Cataract Due to a GFER Variant in an Iranian Family
- 8 October 2025
- Published by Springer Nature in Current Genetic Medicine Reports
- Vol. 13 (1) , 1-9
Myo-Neuropathy and Congenital Bilateral Cataract Due to a GFER Variant in an Iranian Family
- Open Access
- 1 September 2023
- Published by Negah Scientific Publisher in Basic and Clinical Neuroscience Journal
- Vol. 14 (5) , 675-686
Investigating the Association Between Muscular Ultrasonographic Alterations and Clinical Symptoms in Patients With Inflammatory Myopathy
Introduction: Muscle biopsy is commonly used to diagnose inflammatory myopathies. We evaluated the ability of muscle ultrasound, a non-invasive and simple tool, to distinguish between healthy subjects and patients with inflammatory myopathy. Methods: This study was conducted on 17 patients recently diagnosed with biopsy inflammatory myopathies (12 dermatomyositis, 5 polymyositis) compared with 17 age- and gender-matched healthy control adults. All patients underwent clinical assessments, including manual muscle testing, hand-held dynamometry, and muscle ultrasound evaluations, including thickness and echo intensity in predefined muscle groups. Results: The disease duration was seven months (interquartile range: 3 to 11 months). Except for the biceps and gastrocnemius, patients' muscles had significantly higher echo intensity and lower thickness than the control group. The echo intensity sum-score manifested the highest area under the curve compared to the sum-scores of other variables (echo intensity vs manual muscle testing: Area under curves-difference=0.18, P<0.01; echo intensity vs dynamometry: Area under curves-difference=0.14, P=0.02; echo intensity vs thickness: Area under curves-differences-difference=0.25, P<0.01). Conclusion: The echo intensity of muscles differed significantly between healthy individuals and patients with inflammatory myopathies and may serve as a useful diagnostic biomarker.
- 1 September 2023
- Published by Negah Scientific Publisher in Basic and Clinical Neuroscience Journal
- Vol. 14 (5) , 675-686
Open AccessInvestigating the Association Between Muscular Ultrasonographic Alterations and Clinical Symptoms in Patients With Inflammatory Myopathy
Introduction: Muscle biopsy is commonly used to diagnose inflammatory myopathies. We evaluated the ability of muscle ultrasound, a non-invasive and simple tool, to distinguish between healthy subjects and patients with inflammatory myopathy. Methods: This study was conducted on 17 patients recently diagnosed with biopsy inflammatory myopathies (12 dermatomyositis, 5 polymyositis) compared with 17 age- and gender-matched healthy control adults. All patients underwent clinical assessments, including manual muscle testing, hand-held dynamometry, and muscle ultrasound evaluations, including thickness and echo intensity in predefined muscle groups. Results: The disease duration was seven months (interquartile range: 3 to 11 months). Except for the biceps and gastrocnemius, patients' muscles had significantly higher echo intensity and lower thickness than the control group. The echo intensity sum-score manifested the highest area under the curve compared to the sum-scores of other variables (echo intensity vs manual muscle testing: Area under curves-difference=0.18, P<0.01; echo intensity vs dynamometry: Area under curves-difference=0.14, P=0.02; echo intensity vs thickness: Area under curves-differences-difference=0.25, P<0.01). Conclusion: The echo intensity of muscles differed significantly between healthy individuals and patients with inflammatory myopathies and may serve as a useful diagnostic biomarker.
- Open Access
- 2 December 2022
- Published by Wiley in Clinical Case Reports
- Vol. 10 (12) , e6661
Cerebrotendinous xanthomatosis and infertility: A case report
Cerebrotendinous xanthomatosis (CTX) is a lipid storage disorder that causes neurological, ophthalmic, vascular, and musculoskeletal disorders due to the deposition of cholesterol in the tissues. Hence, we report clinical and imaging of a 31‐year‐old mentally retarded man with cerebellar ataxia, bilateral swelling of the posterior aspect of Achill, and infertility.
- 2 December 2022
- Published by Wiley in Clinical Case Reports
- Vol. 10 (12) , e6661
Open AccessCerebrotendinous xanthomatosis and infertility: A case report
Cerebrotendinous xanthomatosis (CTX) is a lipid storage disorder that causes neurological, ophthalmic, vascular, and musculoskeletal disorders due to the deposition of cholesterol in the tissues. Hence, we report clinical and imaging of a 31‐year‐old mentally retarded man with cerebellar ataxia, bilateral swelling of the posterior aspect of Achill, and infertility.
- 21 May 2022
- Published by Elsevier
- p. 141-150
Thunderclap headache